The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Publication date: Jul 17, 2020

This study is a multi-center, randomized, double-blind, parallel, placebo-controlled, phase ? clinical trial to evaluate efficacy and safety of Pyramax in mild to moderate COVID-19 patients.

Concepts Keywords
Abdominal Pain Clinical research
Air Intensive care medicine
Airway Medical specialties
Anemia Medicine
Antiviral Health
Arrhythmia Contraception
Blood Cancer Mechanical ventilation
Cap Female sterilization
Cardiovascular Vasectomy
Cardiovascular Disease Dialysis
Chronic Kidney Disease Extracorporeal membrane oxygenation
Chronic Pulmonary Disease Severe pneumonia
Clinical Trial Chronic liver disease
Condoms Abdominal pain
Contraception SARS
Contraceptive Chronic pulmonary disease
Diabetes Mellitus Cancer treatment
Dialysis Clinical trial
Diaphragm Design of experiments
Double Blind Pharmaceutical industry
Extracorporeal Membrane Oxygenation Birth control
HBV Mechanical ventilation
HCV Dialysis
Hemoglobin
HIV
Immunosuppressants
Infection
Informed Consent
IUDs
Jaundice
Lactating
Male Contraceptive
Mechanical Ventilation
Nasopharyngeal
Nausea
Obese
Oropharyngeal
Oxygen
PCR
Placebo
Pneumonia
QTc Interval Prolongation
Randomization
SARS
Sputum
Sterilization
Tubal Ligation
Upper Airway
Vasectomy

Semantics

Type Source Name
disease MESH infection
drug DRUGBANK Oxygen
drug DRUGBANK Medical air
disease MESH pneumonia
disease MESH cardiovascular disease
disease MESH arrhythmia
disease MESH anemia
disease MESH jaundice
disease MESH Viral disease
disease IDO antiviral
disease MESH diabetes mellitus
disease MESH disease chronic
disease MESH pulmonary disease
disease MESH cancer

Original Article